What's the Problem?

One in six people will die from cancer, and current treatments often come with severe side effects and high chances of recurrence. For brain cancer specifically, existing therapies fail in 95% of patients. There is a significant need for more effective and less toxic treatments.

How are they Solving it?

SphereBio develops personalized cancer vaccines using OncoSpheres, nanoparticles that carry tumor-specific neoantigens to train immune cells to target and eliminate cancer cells. This approach harnesses the patient's own tumor tissue, ensuring precise targeting without the limitations of in silico antigen prediction. This technology provides a safer and more effective treatment option.

Go to their website

Next Startup

Future Biome

Go back to portfolio